MedGen (MDIN) Stock Statistics & Valuation Metrics
Total Valuation
MedGen has a market cap or net worth of $3,010.00. The enterprise value is $31.10B.
- Market Cap
- $3,010.00
- Enterprise Value
- $31.10B
Share Statistics
MedGen has 3,010,314,700 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 3,010,314,700
- Owned by Insiders
- ―
- Owned by Institutions
- ―
Financial Efficiency
MedGen’s return on equity (ROE) is 0.36 and return on invested capital (ROIC) is 81.13%.
- Return on Equity (ROE)
- 0.36
- Return on Assets (ROA)
- 0.00
- Return on Invested Capital (ROIC)
- 81.13%
- Return on Capital Employed (ROCE)
- 0.36
- Revenue Per Employee
- 0
- Profits Per Employee
- ―
- Employee Count
- 3
- Asset Turnover
- 0.00
- Inventory Turnover
- 0.00
Income Statement
In the last 12 months, MedGen had revenue of 0 and earned ― in profits. Earnings per share was 0.00.
- Revenue
- 0
- Gross Profit
- 0
- Operating Income
- ―
- Pretax Income
- ―
- Net Income
- ―
- EBITDA
- ―
- Earnings Per Share (EPS)
- 0.00
Stock Price Statistics
- Beta
- 0.00
- 52-Week Price Change
- ―
- 50-Day Moving Average
- ―
- 200-Day Moving Average
- ―
- Relative Strength Index (RSI)
- ―
- Average Volume (3m)
- ―
Financial Position
MedGen as a current ratio of 0.00, with Debt / Equity ratio of -57.13%
- Current Ratio
- 0.00
- Quick Ratio
- 0.00
- Debt to Market Cap
- 0.00
- Net Debt to EBITDA
- -1.59
- Interest Coverage Ratio
- 0.00
Taxes
In the past 12 months, MedGen has paid 0 in taxes.
- Income Tax
- 0
- Effective Tax Rate
- 0.00
Analyst Forecast
The average price target for MedGen is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- 0
- Revenue Growth Forecast
- ―
- EPS Growth Forecast
- ―
